Abstract
Until now, automatic contrast agent injector syringes licensed for consecutive one-time use have been employed with a number of patients. In 2016, regulation of automatic injector syringes ensured their single use, and reuse was strictly limited by law. However, this regulation creates the social problems of rising medical costs and resource waste. Many doctors are not significantly concerned about infection from contrast agent injection because the needle and connection lines on the patient side are set up for single use, the connections between syringes and contrast agents are reusable, and there are no reports of excessive infection. However, infection can nevertheless occur with injection of contrast agents. We should therefore implement the correct and safe use of contrast agents and take precautions against infection. To prevent infection due to contrast agents, syringes and connection lines for injection of such agents should be used once per patient, or multi-use licensed products should be used. In the latter case, reverse flow prevention filters must be used on the patient's side.
References
2. Medical Service Act. Act No 16555 (August 27, 2019).
3. Buerke B, Mellmann A, Stehling C, Wessling J, Heindel W, Juergens KU. Microbiologic contamination of automatic injectors at MDCT: experimental and clinical investigations. AJR Am J Roentgenol 2008;191:W283–W287.
4. Buerke B, Puesken M, Mellmann A, Seifarth H, Heindel W, Wessling J. Microbiologic contamination and time efficiency of use of automatic MDCT injectors with prefilled syringes: results of a clinical investigation. AJR Am J Roentgenol 2010;194:299–303.
5. Buerke B, Puesken M, Mellmann A, Schuelke C, Knauer A, Heindel W, Wessling J. Automatic MDCT injectors: hygiene and efficiency of disposable, prefilled, and multidosing roller pump systems in clinical routine. AJR Am J Roentgenol 2011;197:W226–W232.
6. Yoshida J, Ishimaru T, Fujimoto M, Hirata N, Matsubara N, Koyanagi N. Risk factors for central venous catheter-related bloodstream infection: a 1073-patient study. J Infect Che-mother 2008;14:399–403.
7. Lee DH, Jung KY, Choi YH. Use of maximal sterile barrier precautions and/or antimicrobial-coated catheters to reduce the risk of central venous catheter-related bloodstream infection. Infect Control Hosp Epidemiol 2008;29:947–950.
8. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med 1991;114:845–854.